Literature DB >> 20561651

[Spanish version of the Cancer Worry Scale (CWS). Cross cultural adaptation and validity and reliability analysis].

Esther Cabrera1, Adelaida Zabalegui, Ignacio Blanco.   

Abstract

BACKGROUND AND OBJECTIVES: The worry for falling ill has been described as a key element in the change of preventive attitudes. Levels of cancer worry not well fitted have been associated with inadequate adherence to preventive strategies. There is not a Spanish validated scale to evaluate the degree of worry for the cancer in our population. The aim of the present study was to perform the cross cultural adaptation and validation of the Cancer Worry Scale described by Lerman. PATIENTS AND
METHOD: A translation, re-translation of the Cancer Worry Scale to Spanish was done. Validation of the Spanish scale was performed by means of the factorial analysis of principal components with the rotation varimax test in a sample of 200 healthy women with family history of breast cancer.
RESULTS: The Escala de Preocupación por el Cáncer (EPC) is the Spanish version of the Cancer Worry Scale and it contains 6 items with a total value ranging from 6 (minimal worry) to 24 (maximum worry). The analysis of content validity demonstrated that the EPC is conceptually equivalent to the original scale. The factorial analysis showed a unique factor that explains 53.07% of the variance confirming the unique dimension. The EPC presented good reliability test - re-test with an Intraclass Correlation Coefficient of 0.777. The Cronbach's alpha was 0.835 for the complete of the scale.
CONCLUSIONS: The EPC is a validated Spanish scale to measure the cancer worry in healthy individuals, which shows a correct content validity and reliability. Copyright Â
© 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20561651     DOI: 10.1016/j.medcli.2010.04.015

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  7 in total

1.  Correlates of Dominicans' Identification of Cancer as a Worrisome Health Problem.

Authors:  Alsacia L Sepulveda-Pacsi; Suzanne Bakken
Journal:  J Immigr Minor Health       Date:  2017-10

2.  Using an informed consent in mammography screening: a randomized trial.

Authors:  José M Baena-Cañada; Petra Rosado-Varela; Inmaculada Expósito-Álvarez; Macarena González-Guerrero; Juan Nieto-Vera; Encarnación Benítez-Rodríguez
Journal:  Cancer Med       Date:  2015-09-17       Impact factor: 4.452

3.  Properties of a scale of concern for COVID-19: Exploratory analysis in a Peruvian sample.

Authors:  Percy G Ruiz Mamani; Wilter C Morales-García; Michael White; Mayte S Marquez-Ruiz
Journal:  Med Clin (Barc)       Date:  2020-07-09       Impact factor: 1.725

4.  Validity and Reliability of the Turkish Version of the Modified Breast Cancer Worry Scale.

Authors:  Sermin Timur Taşhan; Tuba Uçar; Yeşim Aksoy Derya; Gülçin Nacar; Behice Erci
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

5.  Properties of a scale of concern for COVID-19: Exploratory analysis in a Peruvian sample.

Authors:  Percy G Ruiz Mamani; Wilter C Morales-García; Michael White; Mayte S Marquez-Ruiz
Journal:  Med Clin (Engl Ed)       Date:  2020-11-22

6.  Patients' and professionals' perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic.

Authors:  Adrià López-Fernández; Guillermo Villacampa; Elia Grau; Mónica Salinas; Esther Darder; Estela Carrasco; Sara Torres-Esquius; Silvia Iglesias; Ares Solanes; Neus Gadea; Angela Velasco; Gisela Urgell; Maite Torres; Noemí Tuset; Joan Brunet; Sergi Corbella; Judith Balmaña
Journal:  Genet Med       Date:  2021-04-06       Impact factor: 8.822

7.  Factors Associated With Cancer Worry Among People Aged 50 or Older, Spain, 2012-2014.

Authors:  Jesús López-Torres Hidalgo; Joseba Rabanales Sotos; María José Simarro Herráez; Monchi Campos Rosa; Jaime López-Torres López; María Pilar Sánchez Ortiz
Journal:  Prev Chronic Dis       Date:  2015-12-24       Impact factor: 2.830

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.